Back to 
BlackRock, Inc.
BlackRock, Inc.
AVLN1 quarters
Position history for BlackRock, Inc.'s holdings in AVALYN PHARMACEUTICALS INC
BlackRock, Inc. holds 977,264 shares of AVLN (AVALYN PHARMACEUTICALS INC), worth $32.2M as of 2026-Q2. This is a new position. AVLN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$32.2M
Current Shares
977,264
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of AVLN: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, CITADEL ADVISORS LLC, JENNISON ASSOCIATES LLC